<DOC>
	<DOC>NCT00815126</DOC>
	<brief_summary>This study aims to compare the efficacy of nasal provocation test with Lysine-Acetylsalicylate in patients with history of NSAIDs hypersensitivity between mucocutaneous symptoms and respiratory symptoms and laboratory outcomes.</brief_summary>
	<brief_title>Nasal Provocation Test With Lysine-Acetylsalicylate (ASA) in Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
	<mesh_term>Acetylsalicylic acid lysinate</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Patients with history of ASA/NSAIDs hypersensitivity with mucocutaneous symptoms and/or respiratory symptoms Patients who cannot discontinue drugs before the test as follow Nasal corticosteroids/Oral corticosteroids/Leukotriene modifiers for 1 week Shortacting antihistamines for 3 days Nasal amimetics/Oral amimetics/Local cromones for 24 hours Contraindicated for nasal provocation test: pregnant, exacerbation of allergic rhinitis/asthma, having upper respiratory tract infection within 2 weeks prior to the test, having nose surgery within 8 weeks prior to the test, having severe systemic disease(s) Having factors interfere nasal provocation test with LysineASA such as massive nasal polyp, nasal septal perforation, total nasal obstruction at least 1 nostril</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>